0001213900-21-036355.txt : 20210709
0001213900-21-036355.hdr.sgml : 20210709
20210709160656
ACCESSION NUMBER: 0001213900-21-036355
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210707
FILED AS OF DATE: 20210709
DATE AS OF CHANGE: 20210709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lowdell Mark William
CENTRAL INDEX KEY: 0001767037
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 211082917
MAIL ADDRESS:
STREET 1: THE OAK, WLX ROAD
CITY: BEAUMONT
STATE: X0
ZIP: CO16 0AT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-07
0
0001711754
Inmune Bio, Inc.
INMB
0001767037
Lowdell Mark William
C/O INMUNE BIO INC.
980 NORTH FEDERAL HIGHWAY, SUITE 110
BOCA RATON,
FL
33432
0
1
0
0
Chief Scientific Officer
Common Stock
2021-07-07
2021-07-07
4
S
0
5850
20.02
D
1500401
D
Common Stock
2021-07-08
2021-07-08
4
S
0
24150
20.19
D
1476251
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.04, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.48, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.
/s/ Mark William Lowdell
2021-07-09